A C-Suite Perspective: Q&A with Greg Griesemer, VP of Human Resources at G&W Labs
G&W Laboratories today announced the appointment of Jay Galeota to the position of President and Chief Operating Officer.
FTC Puts Conditions on Generic Drug Marketer Lupin Ltd.’s Proposed Acquisition of Gavis Pharmaceuticals LLC
“The proposed consent order preserves competition by requiring the companies to divest these products to the New Jersey-based generic pharmaceutical company G&W Laboratories
G&W Laboratories, a small generic drugmaker, recently broke onto the pharma scene publicly with two substantial deals in 10 months for plants and products.
The Board of Directors of G&W Laboratories has appointed Dr. Aaron Greenblatt as its new Chief Executive Officer.
Teva Pharmaceutical Industries Ltd. has agreed to sell its Pennsylvania facilities to G&W Laboratories Inc. as part of the Israeli company’s cost-reduction program.
For the second time in about 9 months, a privately held New Jersey company has saved a manufacturing plant from closing and hundreds of jobs from being lost.